VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 181 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 5.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $148,000 | -8.1% | 14,975 | +1.4% | 0.56% | +19.0% |
| Q2 2022 | $161,000 | -5.8% | 14,766 | -2.2% | 0.47% | +20.4% |
| Q1 2022 | $171,000 | -43.8% | 15,101 | -22.0% | 0.39% | -19.1% |
| Q4 2021 | $304,000 | -22.4% | 19,359 | -15.4% | 0.49% | +2.3% |
| Q3 2021 | $392,000 | -38.9% | 22,878 | -23.4% | 0.48% | -36.9% |
| Q2 2021 | $642,000 | +33.8% | 29,886 | -6.5% | 0.75% | +42.6% |
| Q1 2021 | $480,000 | +130.8% | 31,959 | +104.4% | 0.53% | +132.6% |
| Q3 2019 | $208,000 | +22.4% | 15,634 | +29.7% | 0.23% | +158.0% |
| Q2 2019 | $170,000 | – | 12,052 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |